SCHEMBL26065982

SCHEMBL26065982

COCCOCCCN1CCN(S(=O)(=O)c2ccc(C(F)(F)F)nc2C)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ MAPT P10636 4/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ LMNA P02545 3/20 0.38
▸ DRD2 P14416 7/20 0.37
▸ DRD3 P35462 7/20 0.37
▸ TRPV4 Q9HBA0 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26066022 0.92 L3MBTL1 (0.41) L3MBTL1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL26065997 0.84 L3MBTL1 (0.38) L3MBTL1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL26066053 0.82 L3MBTL1 (0.45) L3MBTL1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL26066023 0.82 TRPV4 (0.38) L3MBTL1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL26066052 0.81 DRD2 (0.44) MEN1KMT2AMAPTDRD2DRD3
SCHEMBL26066051 0.80 KMT2A (0.43) L3MBTL1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL26065980 0.79 POLB (0.54) MEN1KMT2AMAPTSMN1; SMN2TRPV4
SCHEMBL25373588 0.79 TRPV4 (0.40) KMT2AMAPTLMNADRD2DRD3
SCHEMBL30567039 0.79 TRPV4 (0.40) KMT2AMAPTLMNADRD2DRD3
SCHEMBL26066000 0.78 SMN1; SMN2 (0.41) L3MBTL1MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164063-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-31 — — WO disclosed
Send feedback